Sanofi (SNY) stock analysis

In our weekly check, Sanofi is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3.

About Sanofi

Sanofi is a Healthcare company (Drug Manufacturers - General) based in France, listed on NASDAQ as SNY.

What our checks show for SNY

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-04

Similar companies

BMY · GSK · PFE · NVO · GILD · AMGN

Questions

What grade does Sanofi (SNY) have?

In our weekly check, Sanofi is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SNY stock?

This week's biggest flags for Sanofi: Margins falling, Dividend stretched, Slow recovery after falls. In total 8 of 25 checks show a warning or a red flag.

What does Sanofi do?

Sanofi is a Healthcare company (Drug Manufacturers - General) based in France, listed on NASDAQ as SNY.

When does Sanofi report earnings next?

The next earnings report is expected on 2027-02-04. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis